Skip to main content

JPMORGAN CHASE & CO

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY

Position in CRNX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$51,079,419
+$2,967,481 QoQ
Shares Held
1,365,030
+3.0% QoQ
Ownership
1.29%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 264 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. CRNX ranks #31 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRNX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51,079,419 1,365,030
2026-03-31 $48,111,938 1,324,668
2025-12-31 $53,751,748 1,154,710
2025-09-30 $52,425,767 1,258,722
2025-06-30 $9,547,079 331,957
2025-03-31 $8,904,700 265,495
2024-12-31 $13,781,730 269,543
2024-09-30 $14,612,348 285,956
2024-06-30 $12,767,924 285,062
2024-03-31 $17,599,902 375,986
2023-12-31 $3,312,639 93,104
2023-09-30 $1,618,747 54,430
2023-06-30 $787,005 43,674
2023-03-31 $650,638 40,513
2022-12-31 $634,899 34,694
2022-09-30 $642,030 32,690
2022-06-30 $576,079 30,889
2022-03-31 $1,794,103 81,736
2021-12-31 $1,371,434 48,273
2021-09-30 $485,412 23,060
2021-06-30 $379,656 20,141
2021-03-31 $1,025,347 67,104
2020-12-31 $1,114,801 79,008
2020-09-30 $158,063 10,087
2020-06-30 $160,044 9,135
2020-03-31 $53,699 3,653